PLRX — Pliant Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapValue Trap

Annual balance sheet for Pliant Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	277	201	331	494	356
Net Total Accounts Receivable
Net Total Receivables	9.36	2.08	2.07	3	2.3
Prepaid Expenses
Total Other Current Assets
Total Current Assets	291	209	340	506	362
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.32	10.9	9.91	4.78	32.8
Other Long Term Assets
Total Assets	296	221	351	512	397
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	11.6	16.8	23.9	28.5	33.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	12.5	22.2	37.3	38.6	92.9
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	283	199	313	474	304
Total Liabilities & Shareholders' Equity	296	221	351	512	397
Total Common Shares Outstanding